medigraphic.com
ISSN 2007-8013 (Impreso)
Órgano oficial de la Universidad Autónoma de Sinaloa

2024, Número 1

<< Anterior Siguiente >>

Rev Med UAS 2024; 14 (1)


Estreñimiento crónico: Un artículo de revisión

Ibarra-Castañeda DR, Kawano-Soto CA, Gómez-Castaños PC

Idioma: Español
Referencias bibliográficas: 40
Paginas: 56-70
Archivo PDF: 472.13 Kb.


RESUMEN

La relevancia del estreñimiento crónico para la salud pública es objeto de amplio estudio debido a su creciente incidencia, al impacto económico negativo que produce y a las múltiples complicaciones que conduce, concluyendo en un deterioro de la calidad de vida de los pacientes que lo padecen. Además, aún faltan estrategias para el abordaje de estudio y de tratamiento concisas. Con el reciente desarrollo de diferentes técnicas diagnósticas ha sido posible dilucidar varios de los mecanismos fisiopatológicos por los que se desarrolla esta patología, lo que ha ayudado en gran medida a la creación de estrategias de identificación más temprana de este padecimiento y su clasificación, para administrar tratamientos dirigidos a los blancos terapéuticos identificados. En esta revisión se ofrece una actualización en dichas estrategias de abordaje diagnóstico y terapéutico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Remes J, Coss E, López A, Amieva M, Car-mona R, Charúa L, et al. Consenso mexi-cano de estreñimiento crónico. Rev Gastro-enterol Mex 2018;83(2):168-189.

  2. Lacy B, Mearin F, Chang L, Chey W, Lembo A, Simren M et al. Bowel Disorders. Gastro-enterol 2016;150(6):1393-1407.

  3. Bouras E, Vazquez-Roque M. Epidemiology and management of chronic constipation in elderly patients. Clin Interv Aging 2015; 10(1):919.

  4. Shah E, Almario C, Spiegel B, Chey W. Lo-wer and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bo-wel Syndrome With Constipation or Chronic Idiopathic Constipation. J Neurogastroente-rol Motil 2018;24(2):299-306.

  5. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irri-table bowel syndrome: a systematic review.Aliment Pharmacol Ther 2002;16:1171-1185.

  6. Koloski N, Jones M, Young M, Talley N. Dif-ferentiation of functional constipation and constipation predominant irritable bowel syn-drome based on Rome III criteria: a popula-tion-based study. Aliment Pharmacol Ther 2015;41(9):856-866.

  7. Dennison C, Prasad M, Lloyd A, Samir K, Dhawan R, Coyne K. The health-related quality of life and economic burden of cons-tipation. Pharmacoeconomics 2005;23 (5): 461–476.

  8. Rao S. Constipation: evaluation and treat-mentof colonic and anorectal motility disor-ders. Gastroenterol Clin. North Am 2007; 36 (3): 687–711.

  9. Rao S, Rattanakovit K, Patcharatrakul T. Diagnosis and management of chronic cons-tipation in adults. Nat Rev Gastroenterol He-patol 2016;13(5):295-305.

  10. Mugie S, Benninga M, Di Lorenzo C. Epide-miology of constipation in children and adults: A systematic review. Best Pract Res Clin Gastroenterol 2011;25(1):3-18.

  11. Remes JM, Carmona R, González M, Martí-nez J, Gómez O, Ramírez A, et al. ¿Qué se entiende por estreñimiento? un estudio en población abierta. Red Gastroenterol Mex 2018; 74(4): 321-328.

  12. Dukas L, Willett W, Giovannucci E. Associa-tion between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am. J. Gastroenterol 2003; 98 (8):1790–1796.

  13. Coremans G, Margaritis V, Gebruers K. Is there a genetic component in chronic fun-ctional constipation? Gastroenterol 2005; 128(2):A272.

  14. Locke G, Zinsmeister A, Fett S, Melton L, Ta-lley N. Overlap of gastrointestinal symptom complexes in a US community. Neurogastro-enterol Motil 2005: 17 (1): 29–34.

  15. Velarde J, Morales M, Coss E, Gómez O, Rendón R, Vázquez G, et al. Prevalencia de sobreposición de trastornos funcionales di-gestivos: Resultados de un estudio nacional (SIGAME 2). Rev Med MD 2019; 10(2): 107-112.

  16. Burgell R, Lelic D, Carrington E, Lunnis P, Olesen S, Surgury S, et al. Assessment of rectal afferent neuronal function and brain activity in patients with constipation and rec-tal hyposensitivity. Neurogastroenterol Motil 2013; 25 (3):260–268.

  17. Ohkusa T, Koido S, Nishikawa Y, Sato N. Gut Microbiota and Chronic Constipation: A Review and Update. Front Med 2019;6 (2):7-19

  18. Bharucha A, Pemberton J, Locke G. Ameri-can Gastroenterological Association techni-cal review on constipation. Gastroenterol 2013; 144(1): 218–238.

  19. Satish R, Sadeghi P, Beaty J, Kavlock R. Ambulatory 24-hour colonic manometry in slow- transit constipation. Am J Gastroente-rol 2004; 99 (12):2405–2416.

  20. Dinning P, Di Lorenzo C. Colonic dysmotility in constipation. Best Pract. Res. Clin. Gas-troenterol 2011; 25 (2):89–101.

  21. Rattanakovit K, Rao S, Amieva M, Mack A, Dewitt A. Dyssynergia or no dyssynergia: phenotypic categorization of constipated pa-tients with high resolution anorectal mano-metry (HRAM). Am. J. Gastroenterol 2015; 110(1): S593.

  22. Wald A. Constipation Advances in Diagnosis and Treatment. MD JAMA. 2016;315(2):185-191.

  23. Schmulson M, Francisconi C, Olden K, Agui-lar L, Bustos L, Cohen H, et al. The latina-merican consensus on chronic constipation. Gastroenterol Hepatol 2008;31 (2):59-67.

  24. Lacy B, Mearin F, Chang L, Mearin L, Chey W, Lembo A, et al. Bowel disorders. Gastro-enterol 2016;150 (16):1393-407.

  25. Bouras E, Vazquez M. Epidemiology, and management of chronic constipation in el-derly patients. Clin Interv Aging. 2015;10(1):919-30

  26. Tantiphlachiva K, Rao P, Attaluri A, Rao S. Digital rectal examination is a useful tool for identifying patients with dyssyner-gia. Clin. Gastroenterol. Hepatol 2010: 8: 955–960.

  27. Tornblom H, Van L, Sadik R, Hasse A, Tack J, Simren M, et al. Colonic transit time and IBS symptoms: what’s the link? Am J Gas-troenterol 2012; 107 (5): 754–760.

  28. Chiarioni G, Kim S, Vantini I, Whitehead W. Validation of the balloon evacuation test: re-producibility and agreement with findings-from anorectal manometry and elec-tromyography. Clin Gastroenterol. Hepatol 2014; 12(2): 2049–2054.

  29. Reiner CS, Tutuian R, Solopova AE, Pohl D, Marineck B. MR defecography in patients with dyssynergic defecation: Spectrum of imaging findings and diagnostic value. Br J Radiol 2011;84 (998): 136-44.

  30. Rao S, Kuo B, McCallum R, Chey W, DiBaise J, Hasler W et al. Investigation of Colonic and Whole-Gut Transit With Wire-less Motility Capsule and Radiopaque Mar-kers in Constipation. Clin Gastroenterol He-patol 2009;7(5):537-544.

  31. Chan AOO, Leung G, Tong T, Wong N. In-creasing dietary fiber intake in terms of kiwi-fruit improves constipation in Chinese pa-tients. World J Gastroenterol. 2007;13:4771-5.

  32. Christodoulides S, Dimidi E, Fragkos KC. Systematic review with meta-analysis: Effect of fibre supplementation on chronic idiopat-hic constipation in adults. Aliment Pharmacol Ther. 2016;44:103-16.

  33. Lee H, Thomas K, Morgan J, Nelson R. Lac-tulose versus Polyethylene Glycol for Chro-nic Constipation. Cochrane Database of Syst Rev 2010; 7(7): CD007570.

  34. Kamm M, Mueller–Lissner S, Wald A, Rich-ter E, Swallow R, Gessner U. Oral Bisacodyl Is Effective and Well-Tolerated in Patients With Chronic Constipation. Clin Gastroente-rol Hepatol 2011;9(7):577-583.

  35. Mueller S, Kamm M, Wald A, Hinkel U, Koe-hler U, Richter E et al. Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Con-trolled Trial of Sodium Picosulfate in Patients With Chronic Constipation. Am J Gastroen-terol 2010;105(4):897-903.

  36. Layer P, Keller J, Loeffler H, Kreiss A. Tega-serod in the treatment of irritable bowel syn-drome (IBS) with constipation as the prime symptom. Ther Clin Risk Manag 2007;3(1):107-118.

  37. Camilleri M, Piessevaux H, Yiannakou Y, Tack J, Kerstens R, Quigley E et al. Efficacy and Safety of Prucalopride in Chronic Cons-tipation: An Integrated Analysis of Six Ran-domized, Controlled Clinical Trials. Dig Dis Sci 2016;61(8):2357-2372.

  38. Siemens W, Gaertner J, Becker G. Advan-ces in pharmacotherapy for opioid-induced constipation a systematic review. Expert Opin. Pharmacother 2016; 16 (4): 515–532.

  39. Chey W, Webster L, Sostek M, Jakko L, Bar-ker P, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl. J Med 2014: 370(25): 2387–2396.

  40. Rao S, Bennigna M, Bharucha A, Chiaroni G, Lorenzo C, Whitehead W, et al. ANMS-ESNM position paper and consensus guide-lines on biofeedback therapy for anorectal disorders. Neurogastroenterol. Motil 2013; 27 (5):594–609.




2020     |     www.medigraphic.com